Carter Bankshares (CARE) Cash & Equivalents (2020 - 2026)

Carter Bankshares (CARE) has 3 years of Cash & Equivalents data on file, last reported at $65.7 million in Q3 2022.

• Quarterly Cash & Equivalents fell 70.9% year-over-year to $65.7 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $65.7 million (down 70.9% YoY) and the FY2021 annual result came in at $277.8 million, up 14.82% from the prior year.
• Cash & Equivalents fell to $65.7 million in Q3 2022, from $70.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $277.8 million in Q4 2021 to a low of $65.7 million in Q3 2022.
• A 3-year average of $178.2 million and a median of $217.9 million in 2021 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2021 — Cash & Equivalents rose 14.82% — and 2022, when it slumped 70.9%.
• Tracing CARE's Cash & Equivalents over 3 years: stood at $241.9 million in 2020, then increased by 14.82% to $277.8 million in 2021, then plunged by 76.35% to $65.7 million in 2022.
• The last three Cash & Equivalents figures came in at $65.7 million (Q3 2022), $70.2 million (Q2 2022), and $108.0 million (Q1 2022), per Business Quant data.